Generic placeholder image

Current Drug Discovery Technologies

Editor-in-Chief

ISSN (Print): 1570-1638
ISSN (Online): 1875-6220

Mini-Review Article

CBD: A Potential Lead against Hair Loss, Alopecia, and its Potential Mechanisms

Author(s): Pranay Wal* and Ankita Wal

Volume 21, Issue 2, 2024

Published on: 01 September, 2023

Article ID: e200723218949 Pages: 9

DOI: 10.2174/1570163820666230720153607

Price: $65

Abstract

Background: Nowadays, the majority of the population suffers from the problem of hair loss. It leads to disturbed mental health, lower self-confidence, and a lot more problems. A lot of the hair loss therapies available are not reliable and lead to recurrence and side effects after some time. Cannabinoids (CBD) have recently become quite popular for their benefits against hair loss. CBD oil preparations have been used both internally and externally for oral and topical use, respectively. Due to the presence of the endocannabinoid system (ECS) in the body, which naturally targets CB1 and CB2 receptors, the control of hair fall is possible. CBD is used topically for hair loss, whereas it is administered orally for the treatment and management of a medical condition, i.e., alopecia.

Aim/Objective: The present review aimed to provide an in-depth study on hair loss and its management using CBD and its associated mechanisms.

Methods: Electronic databases, such as ScienceDirect, Google Scholar, PubMed, Wiley, Springer, and Scopus, were thoroughly searched for information about how CBD is used, how it works, and what role it plays in treating alopecia and hair loss.

Results: This review has highlighted the use of CBD-based hair loss therapy, and described various types of hair loss and their treatments. This review also details the phytocannabinoids and the potential mechanisms of CBD's activity against hair loss and alopecia.

Conclusion: The data obtained from the literature regarding CBD and hair loss provide a scientific basis for CBD use in alopecia. Additionally, a more precise and comprehensive study concerning CBD needs to be carried out at the pre-clinical and clinical levels.

Keywords: Endocannabinoid system, cannabinoids, alopecia, hair loss, mental health, anti-inflammatory, antioxidant.

Graphical Abstract
[1]
Gupta, M.; Mysore, V. Classifications of patterned hair loss: a review. J. Cutan. Aesthet. Surg., 2016, 9(1), 3-12.
[http://dx.doi.org/10.4103/0974-2077.178536] [PMID: 27081243]
[2]
Singal, A.; Sonthalia, S.; Verma, P. Female pattern hair loss. Indian J. Dermatol. Venereol. Leprol., 2013, 79(5), 626-640.
[http://dx.doi.org/10.4103/0378-6323.116732] [PMID: 23974580]
[3]
Wu, W.; Wirya, C.T.; Wu, K. Classification of male-pattern hair loss. Int. J. Trichology, 2017, 9(3), 95-100.
[http://dx.doi.org/10.4103/ijt.ijt_46_17] [PMID: 28932058]
[4]
Van Neste, D. Female patients complaining about hair loss: documentation of defective scalp hair dynamics with contrast-enhanced phototrichogram. Skin Res. Technol., 2006, 12(2), 83-88.
[http://dx.doi.org/10.1111/j.0909-752X.2006.00202.x] [PMID: 16626380]
[5]
Stough, D.B.; Miner, J.E. Male pattern alopecia. Surgical options. Dermatol. Clin., 1997, 15(4), 609-622.
[http://dx.doi.org/10.1016/S0733-8635(05)70470-8] [PMID: 9348461]
[6]
Lolli, F.; Pallotti, F.; Rossi, A.; Fortuna, M.C.; Caro, G.; Lenzi, A.; Sansone, A.; Lombardo, F. Androgenetic alopecia: a review. Endocrine, 2017, 57(1), 9-17.
[http://dx.doi.org/10.1007/s12020-017-1280-y] [PMID: 28349362]
[7]
Nestor, M.S.; Ablon, G.; Gade, A.; Han, H.; Fischer, D.L. Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics. J. Cosmet. Dermatol., 2021, 20(12), 3759-3781.
[http://dx.doi.org/10.1111/jocd.14537] [PMID: 34741573]
[8]
Santos, Z.; Avci, P.; Hamblin, M.R. Drug discovery for alopecia: gone today, hair tomorrow. Expert Opin. Drug Discov., 2015, 10(3), 269-292.
[http://dx.doi.org/10.1517/17460441.2015.1009892] [PMID: 25662177]
[9]
Rathnayake, D.; Sinclair, R. Male androgenetic alopecia. Expert Opin. Pharmacother., 2010, 11(8), 1295-1304.
[http://dx.doi.org/10.1517/14656561003752730] [PMID: 20426708]
[10]
Fabbrocini, G.; Cantelli, M.; Masarà, A.; Annunziata, M.C.; Marasca, C.; Cacciapuoti, S. Female pattern hair loss: A clinical, pathophysiologic, and therapeutic review. Int. J. Womens Dermatol., 2018, 4(4), 203-211.
[http://dx.doi.org/10.1016/j.ijwd.2018.05.001] [PMID: 30627618]
[11]
Sehgal, V.N.; Srivastava, G.; Aggarwal, A.K.; Midha, R. Hair biology and its comprehensive sequence in female pattern baldness: diagnosis and treatment modalities--Part I. Skinmed, 2013, 11(1), 39-45.
[PMID: 23540076]
[12]
Egger, A.; Resnik, S.R.; Aickara, D.; Maranda, E.; Kaiser, M.; Wikramanayake, T.C.; Jimenez, J.J. Examining the safety and efficacy of low-level laser therapy for male and female pattern hair loss: a review of the literature. Skin Appendage Disord., 2020, 6(5), 259-267.
[http://dx.doi.org/10.1159/000509001] [PMID: 33088809]
[13]
Nakamura, M.; Schneider, M.R.; Schmidt-Ullrich, R.; Paus, R. Mutant laboratory mice with abnormalities in hair follicle morphogenesis, cycling, and/or structure: An update. J. Dermatol. Sci., 2013, 69(1), 6-29.
[http://dx.doi.org/10.1016/j.jdermsci.2012.10.001] [PMID: 23165165]
[14]
Stone, R.C.; Aviv, A.; Paus, R. Telomere dynamics and telomerase in the biology of hair follicles and their stem cells as a model for aging research. J. Invest. Dermatol., 2021, 141(4), 1031-1040.
[http://dx.doi.org/10.1016/j.jid.2020.12.006] [PMID: 33509633]
[15]
Kelly, Y.; Blanco, A.; Tosti, A. Androgenetic alopecia: an update of treatment options. Drugs, 2016, 76(14), 1349-1364.
[http://dx.doi.org/10.1007/s40265-016-0629-5] [PMID: 27554257]
[16]
Lee, S.W.; Juhasz, M.; Mobasher, P.; Ekelem, C.; Mesinkovska, N.A. A systematic review of topical finasteride in the treatment of androgenetic alopecia in men and women. J. Drugs Dermatol., 2018, 17(4), 457-463.
[PMID: 29601622]
[17]
Ocampo-Garza, J.; Griggs, J.; Tosti, A. New drugs under investigation for the treatment of alopecias. Expert Opin. Investig. Drugs, 2019, 28(3), 275-284.
[http://dx.doi.org/10.1080/13543784.2019.1568989] [PMID: 30642204]
[18]
Dhariwala, M.Y.; Ravikumar, P. An overview of herbal alternatives in androgenetic alopecia. J. Cosmet. Dermatol., 2019, 18(4), jocd.12930.
[http://dx.doi.org/10.1111/jocd.12930] [PMID: 30980598]
[19]
Bagood, M.D.; Isseroff, R.R. TRPV1: role in skin and skin diseases and potential target for improving wound healing. Int. J. Mol. Sci., 2021, 22(11), 6135.
[http://dx.doi.org/10.3390/ijms22116135] [PMID: 34200205]
[20]
Geyfman, M.; Plikus, M.V.; Treffeisen, E.; Andersen, B.; Paus, R. Resting no more: re-defining telogen, the maintenance stage of the hair growth cycle. Biol. Rev. Camb. Philos. Soc., 2015, 90(4), 1179-1196.
[http://dx.doi.org/10.1111/brv.12151] [PMID: 25410793]
[21]
Madaan, A.; Verma, R.; Singh, A.T.; Jaggi, M. Review of Hair Follicle Dermal Papilla cells as in vitro screening model for hair growth. Int. J. Cosmet. Sci., 2018, 40(5), 429-450.
[http://dx.doi.org/10.1111/ics.12489] [PMID: 30144361]
[22]
Dogra, S.; Vinay, K.; Sawatkar, G.U. Hair manifestations of endocrine diseases: A brief review. Indian J. Dermatol. Venereol. Leprol., 2018, 84(5), 528-538.
[http://dx.doi.org/10.4103/ijdvl.IJDVL_671_17] [PMID: 30027913]
[23]
Carlier, J.; Huestis, M.A.; Zaami, S.; Pichini, S.; Busardò, F.P. Monitoring perinatal exposure to cannabis and synthetic cannabinoids. Ther. Drug Monit., 2020, 42(2), 194-204.
[http://dx.doi.org/10.1097/FTD.0000000000000667] [PMID: 32195988]
[24]
Martinelli, G.; Magnavacca, A.; Fumagalli, M. DellʼAgli M, Piazza S, Sangiovanni E. Dissecting the role of phytocannabinoids. Planta Med., 2022, 88(7), 492-506.
[http://dx.doi.org/10.1055/a-1420-5780] [PMID: 33851375]
[25]
Darwin, E.; Hirt, P.; Fertig, R.; Doliner, B.; Delcanto, G.; Jimenez, J. Alopecia areata: Review of epidemiology, clinical features, pathogenesis, and new treatment options. Int. J. Trichology, 2018, 10(2), 51-60.
[http://dx.doi.org/10.4103/ijt.ijt_99_17] [PMID: 29769777]
[26]
Gensure, R.C. Parathyroid hormone-related peptide and the hair cycle - is it the agonists or the antagonists that cause hair growth? Exp. Dermatol., 2014, 23(12), 865-867.
[http://dx.doi.org/10.1111/exd.12504] [PMID: 25041375]
[27]
Tóth, K.; Ádám, D.; Bíró, T.; Oláh, A. Cannabinoid Signaling in the Skin: Therapeutic Potential of the “C(ut)annabinoid” System. Molecules, 2019, 24(5), 918.
[http://dx.doi.org/10.3390/molecules24050918] [PMID: 30845666]
[28]
Rossi, A.; Iorio, A.; Di Nunno, D.; Priolo, L.; Fortuna, M.C.; Garelli, V.; Carlesimo, M.; Calvieri, S.; Mari, E. Conditions simulating androgenetic alopecia. J. Eur. Acad. Dermatol. Venereol., 2015, 29(7), 1258-1264.
[http://dx.doi.org/10.1111/jdv.12915] [PMID: 25571781]
[29]
Dominguez-Santas, M.; Diaz-Guimaraens, B.; Saceda-Corralo, D.; Hermosa-Gelbard, A.; Muñoz-Moreno Arrones, O.; Pindado-Ortega, C.; Fernandez-Nieto, D.; Jimenez-Cauhe, J.; Ortega-Quijano, D.; Suarez-Valle, A.; Jaen-Olasolo, P.; Vaño-Galvan, S. The state‐of‐the‐art in the management of androgenetic alopecia: A review of new therapies and treatment algorithms. JEADV Clin. Pract., 2022, 1(3), 176-185.
[http://dx.doi.org/10.1002/jvc2.53]
[30]
Rojas-Martínez, A.; Martinez-Jacobo, L.; Villarreal-Villarreal, C.D.; Ortiz-López, R.; Ocampo-Candiani, J. Genetic and molecular aspects of androgenetic alopecia. Indian J. Dermatol. Venereol. Leprol., 2018, 84(3), 263-268.
[http://dx.doi.org/10.4103/ijdvl.IJDVL_262_17] [PMID: 29595184]
[31]
Birch, M.P.; Lalla, S.C.; Messenger, A.G. Female pattern hair loss. Clin. Exp. Dermatol., 2002, 27(5), 383-388.
[http://dx.doi.org/10.1046/j.1365-2230.2002.01085.x] [PMID: 12190638]
[32]
Rossi, A.; Anzalone, A.; Fortuna, M.C.; Caro, G.; Garelli, V.; Pranteda, G.; Carlesimo, M. Multi-therapies in androgenetic alopecia: review and clinical experiences. Dermatol. Ther., 2016, 29(6), 424-432.
[http://dx.doi.org/10.1111/dth.12390] [PMID: 27424565]
[33]
Adil, A.; Godwin, M. The effectiveness of treatments for androgenetic alopecia: A systematic review and meta-analysis. J. Am. Acad. Dermatol., 2017, 77(1), 136-141.e5.
[http://dx.doi.org/10.1016/j.jaad.2017.02.054] [PMID: 28396101]
[34]
Gupta, A.K.; Cole, J.; Deutsch, D.P.; Everts, P.A.; Niedbalski, R.P.; Panchaprateep, R.; Rinaldi, F.; Rose, P.T.; Sinclair, R.; Vogel, J.E.; Welter, R.J.; Zufelt, M.D.; Puig, C.J. Platelet-rich plasma as a treatment for androgenetic alopecia. Dermatol. Surg., 2019, 45(10), 1262-1273.
[http://dx.doi.org/10.1097/DSS.0000000000001894] [PMID: 30882509]
[35]
Hordinsky, M.K. Overview of alopecia areata. In: In Journal of Investigative Dermatology Symposium Proceedings; Elsevier, 2013.
[http://dx.doi.org/10.1038/jidsymp.2013.4]
[36]
Otlewska, A.; Otlewska, A.; Szpotowicz, G. Alopecia areata. Paediatrics and Family Medicine., 2019, 15(4), 358.
[37]
Hordinsky, M.; Junqueira, L. Alopecia areata update. Semin. Cutan. Med. Surg., 2015, 34(2), 72-75.
[http://dx.doi.org/10.12788/j.sder.2015.0160] [PMID: 26176283]
[38]
Hay, R.J. Tinea capitis: current status. Mycopathologia, 2017, 182(1-2), 87-93.
[http://dx.doi.org/10.1007/s11046-016-0058-8] [PMID: 27599708]
[39]
Rebollo, N.; López-Barcenas, A.P.; Arenas, R. Tiña de la cabeza. Actas Dermosifiliogr., 2008, 99(2), 91-100.
[http://dx.doi.org/10.1016/S0001-7310(08)74630-1] [PMID: 18346430]
[40]
Brito-Santos, F.; Figueiredo-Carvalho, M.H.G.; Coelho, R.A.; Sales, A.; Almeida-Paes, R. Tinea capitis by Microsporum audouinii: case reports and review of published global literature 2000–2016. Mycopathologia, 2017, 182(11-12), 1053-1060.
[http://dx.doi.org/10.1007/s11046-017-0181-1] [PMID: 28736794]
[41]
Leung, A.K.C.; Lam, J.M.; Leong, K.F.; Hon, K.L. Tinea corporis: an updated review. Drugs Context, 2020, 9, 1-12.
[http://dx.doi.org/10.7573/dic.2020-5-6] [PMID: 32742295]
[42]
Alkeswani, A.; Cantrell, W.; Elewski, B. Treatment of tinea capitis. Skin Appendage Disord., 2019, 5(4), 201-210.
[http://dx.doi.org/10.1159/000495909]
[43]
Zaraa, I.; Hawilo, A.; Trojjet, S.; Euch, D.E.; Mokni, M.; Osman, A.B. Tinea capitis in infants in their first 2 years of life: A 12-year study and a review of the literature. Dermatol. Online J., 2012, 18(7), 16.
[http://dx.doi.org/10.5070/D30519T0B9] [PMID: 22863638]
[44]
Kojima, R.; Fujiwara, T.; Matsuda, A.; Narita, M.; Matsubara, O.; Nonoyama, S.; Ohya, Y.; Saito, H.; Matsumoto, K. Factors associated with steroid phobia in caregivers of children with atopic dermatitis. Pediatr. Dermatol., 2013, 30(1), 29-35.
[http://dx.doi.org/10.1111/j.1525-1470.2012.01808.x] [PMID: 22747965]
[45]
Gupta, A.K.; Mays, R.R.; Versteeg, S.G.; Piraccini, B.M.; Shear, N.H.; Piguet, V.; Tosti, A.; Friedlander, S.F. Tinea capitis in children: a systematic review of management. J. Eur. Acad. Dermatol. Venereol., 2018, 32(12), 2264-2274.
[http://dx.doi.org/10.1111/jdv.15088] [PMID: 29797669]
[46]
Rebora, A. Telogen effluvium: a comprehensive review. Clin. Cosmet. Investig. Dermatol., 2019, 12, 583-590.
[http://dx.doi.org/10.2147/CCID.S200471] [PMID: 31686886]
[47]
Chien Yin, G.O.; Siong-See, J.L.; Wang, E.C.E Telogen Effluvium – a review of the science and current obstacles. J. Dermatol. Sci., 2021, 101(3), 156-163.
[http://dx.doi.org/10.1016/j.jdermsci.2021.01.007] [PMID: 33541773]
[48]
Malkud, S. Telogen effluvium: a review. J. Clin. Diagn. Res., 2015, 9(9), WE01-WE03.
[PMID: 26500992]
[49]
Werner, B.; Mulinari-Brenner, F. Clinical and histological challenge in the differential diagnosis of diffuse alopecia: female androgenetic alopecia, telogen effluvium and alopecia areata - part II. An. Bras. Dermatol., 2012, 87(6), 884-890.
[http://dx.doi.org/10.1590/S0365-05962012000600010] [PMID: 23197208]
[50]
Miteva, M.; Tosti, A. Treatment options for alopecia: an update, looking to the future. Expert Opin. Pharmacother., 2012, 13(9), 1271-1281.
[http://dx.doi.org/10.1517/14656566.2012.685160] [PMID: 22594679]
[51]
Jamerson, T.A.; Aguh, C. An approach to patients with alopecia. Med. Clin. North Am., 2021, 105(4), 599-610.
[http://dx.doi.org/10.1016/j.mcna.2021.04.002] [PMID: 34059240]
[52]
Rebora, A. Telogen effluvium revisited. G. Ital. Dermatol. Venereol., 2014, 149(1), 47-54.
[PMID: 24566565]
[53]
Grant, J. Trichotillomania (hair pulling disorder). Indian J. Psychiatry, 2019, 61(7)(Suppl. 1), 136.
[http://dx.doi.org/10.4103/psychiatry.IndianJPsychiatry_529_18] [PMID: 30745687]
[54]
Torales, J.; Ruiz Díaz, N.; Ventriglio, A.; Castaldelli-Maia, J.M.; Barrios, I.; García, O.; Navarro, R.; González-Urbieta, I.; O’Higgins, M.; Jafferany, M. HAIR‐PULLING disorder (Trichotillomania): Etiopathogenesis, diagnosis and treatment in a nutshell. Dermatol. Ther., 2021, 34(1), e13466.
[http://dx.doi.org/10.1111/dth.14366] [PMID: 33015928]
[55]
Gupta, Y.K.; Briyal, S. Protective effect of vineatrol against kainic acid induced seizures, oxidative stress and on the expression of heat shock proteins in rats. Eur. Neuropsychopharmacol., 2006, 16(2), 85-91.
[http://dx.doi.org/10.1016/j.euroneuro.2005.07.004] [PMID: 16139993]
[56]
Huynh, M.; Gavino, A.C.; Magid, M. Trichotillomania. Semin. Cutan. Med. Surg., 2013, 32(2), 88-94.
[http://dx.doi.org/10.12788/j.sder.0007] [PMID: 24049966]
[57]
Özten, E.; Hızlı Sayar, G.; Kağan, G.; Işık, S.; Karamustafalıoğlu, O.; Eryilmaz, G. The relationship of psychological trauma with trichotillomania and skin picking. Neuropsychiatr. Dis. Treat., 2015, 11, 1203-1210.
[http://dx.doi.org/10.2147/NDT.S79554] [PMID: 26028973]
[58]
Cisoń, H.; Kuś, A.; Popowicz, E.; Szyca, M.; Reich, A. Trichotillomania and trichophagia: modern diagnostic and therapeutic methods. Dermatol. Ther. (Heidelb.), 2018, 8(3), 389-398.
[http://dx.doi.org/10.1007/s13555-018-0256-z] [PMID: 30099694]
[59]
Baczynski, C.; Sharma, V. Pharmacotherapy for trichotillomania in adults. Expert Opin. Pharmacother., 2020, 21(12), 1455-1466.
[http://dx.doi.org/10.1080/14656566.2020.1761324] [PMID: 32633577]
[60]
Lamothe, H.; Baleyte, J.M.; Mallet, L.; Pelissolo, A. Trichotillomania is more related to Tourette disorder than to obsessive-compulsive disorder. Br. J. Psychiatry, 2020, 42(1), 87-104.
[http://dx.doi.org/10.1590/1516-4446-2019-0471] [PMID: 31576938]
[61]
Haskin, A.; Kwatra, S.G.; Aguh, C. Breaking the cycle of hair breakage: pearls for the management of acquired trichorrhexis nodosa. J. Dermatolog. Treat., 2017, 28(4), 322-326.
[http://dx.doi.org/10.1080/09546634.2016.1246704] [PMID: 27718775]
[62]
Rudnicka, L.; Olszewska, M.; Waśkiel, A.; Rakowska, A. Trichoscopy in hair shaft disorders. Dermatol. Clin., 2018, 36(4), 421-430.
[http://dx.doi.org/10.1016/j.det.2018.05.009] [PMID: 30201151]
[63]
Kudligi, C.; Kuntoji, V.; Bhagwat, P.; Asati, D.; Bansal, A. The tricky “trichs” in dermatology! Indian J. Dermatol. Venereol. Leprol., 2018, 84(1), 109-113.
[http://dx.doi.org/10.4103/ijdvl.IJDVL_1019_16] [PMID: 29243672]
[64]
Bhattarai, D.; Banday, A.Z.; Sadanand, R.; Arora, K.; Kaur, G.; Sharma, S.; Rawat, A. Hair microscopy: an easy adjunct to diagnosis of systemic diseases in children. Appl. Microsc., 2021, 51(1), 18.
[http://dx.doi.org/10.1186/s42649-021-00067-6] [PMID: 34843009]
[65]
Taylor, S.C.; Barbosa, V.; Burgess, C.; Heath, C.; McMichael, A.J.; Ogunleye, T.; Callender, V. Hair and scalp disorders in adult and pediatric patients with skin of color. Cutis, 2017, 100(1), 31-35.
[PMID: 28873105]
[66]
Kanwar, A.; Narang, T. Anagen effluvium. Indian J. Dermatol. Venereol. Leprol., 2013, 79(5), 604-612.
[http://dx.doi.org/10.4103/0378-6323.116728] [PMID: 23974578]
[67]
Jafferany, M.; Patel, A. Trichopsychodermatology: the psychiatric and psychosocial aspects of hair disorders. Dermatol. Ther., 2020, 33(1), e13168.
[http://dx.doi.org/10.1111/dth.13168] [PMID: 31714654]
[68]
Kecelj, B.; Kecelj Leskovec, N.; Žgavec, B. A case report and differential diagnosis of pruritic pretibial skin lesions. Acta Dermatovenerol. Alp. Panonica Adriat., 2020, 29(3), 157-159.
[http://dx.doi.org/10.15570/actaapa.2020.32] [PMID: 32975304]
[69]
Yeager, C; Olsen, EA Hair disorders associated with anticancer agents. In: Dermatologic Principles and Practice in Oncology: Conditions of the Skin, Hair, and Nails in Cancer Patients; Wiley Online Library, 2013.
[http://dx.doi.org/10.1002/9781118590638.ch10]
[70]
Burstein, S. CBD Receptor Binding Signaling Events Downstream Events. Bioorg. Med. Chem., 2015.
[71]
Pellati, F.; Borgonetti, V.; Brighenti, V.; Biagi, M.; Benvenuti, S.; Corsi, L. Cannabis sativa L. and nonpsychoactive cannabinoids: their chemistry and role against oxidative stress, inflammation, and cancer. BioMed Res. Int., 2018, 2018, 1-15.
[http://dx.doi.org/10.1155/2018/1691428] [PMID: 30627539]
[72]
Morales, P.; Reggio, P.H.; Jagerovic, N. An overview on medicinal chemistry of synthetic and natural derivatives of cannabidiol. Front. Pharmacol., 2017, 8, 422.
[http://dx.doi.org/10.3389/fphar.2017.00422] [PMID: 28701957]
[73]
Li, H.; Liu, Y.; Tian, D.; Tian, L.; Ju, X.; Qi, L.; Wang, Y.; Liang, C. Overview of cannabidiol (CBD) and its analogues: Structures, biological activities, and neuroprotective mechanisms in epilepsy and Alzheimer’s disease. Eur. J. Med. Chem., 2020, 192, 112163.
[http://dx.doi.org/10.1016/j.ejmech.2020.112163] [PMID: 32109623]
[74]
Nagarkatti, P.; Pandey, R.; Rieder, S.A.; Hegde, V.L.; Nagarkatti, M. Cannabinoids as novel anti-inflammatory drugs. Future Med. Chem., 2009, 1(7), 1333-1349.
[http://dx.doi.org/10.4155/fmc.09.93] [PMID: 20191092]
[75]
Vincenzi, C.; Tosti, A. Efficacy and tolerability of a shampoo containing broad-spectrum cannabidiol in the treatment of scalp inflammation in patients with mild to moderate scalp psoriasis or seborrheic dermatitis. Skin Appendage Disord., 2020, 6(6), 355-361.
[http://dx.doi.org/10.1159/000510896] [PMID: 33313051]
[76]
Valizadehderakhshan, M.; Shahbazi, A.; Kazem-Rostami, M.; Todd, M.S.; Bhowmik, A.; Wang, L. Extraction of cannabinoids from Cannabis sativa L.(Hemp). Agriculture, 2021, 11(5), 384.
[http://dx.doi.org/10.3390/agriculture11050384]
[77]
Ibeas Bih, C.; Chen, T.; Nunn, A.V.W.; Bazelot, M.; Dallas, M.; Whalley, B.J. Molecular targets of cannabidiol in neurological disorders. Neurotherapeutics, 2015, 12(4), 699-730.
[http://dx.doi.org/10.1007/s13311-015-0377-3] [PMID: 26264914]
[78]
Ligresti, A.; De Petrocellis, L.; Di Marzo, V. From phytocannabinoids to cannabinoid receptors and endocannabinoids: pleiotropic physiological and pathological roles through complex pharmacology. Physiol. Rev., 2016, 96(4), 1593-1659.
[http://dx.doi.org/10.1152/physrev.00002.2016] [PMID: 27630175]
[79]
Lowe, H.; Toyang, N.; Steele, B.; Bryant, J.; Ngwa, W. The endocannabinoid system: A potential target for the treatment of various diseases. Int. J. Mol. Sci., 2021, 22(17), 9472.
[http://dx.doi.org/10.3390/ijms22179472] [PMID: 34502379]
[80]
Szabó, I.L.; Herczeg-Lisztes, E.; Szollosi, A.G.; Szegedi, A.; Bíró, T.; Oláh, A. 263 (-)-cannabidiol differentially influences hair growth. J. Invest. Dermatol., 2017, 137(10), S238.
[http://dx.doi.org/10.1016/j.jid.2017.07.261]
[81]
De Petrocellis, L.; Ligresti, A.; Moriello, A.S.; Allarà, M.; Bisogno, T.; Petrosino, S.; Stott, C.G.; Di Marzo, V. Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes. Br. J. Pharmacol., 2011, 163(7), 1479-1494.
[http://dx.doi.org/10.1111/j.1476-5381.2010.01166.x] [PMID: 21175579]
[82]
Di Marzo, V.; Piscitelli, F. The endocannabinoid system and its modulation by phytocannabinoids. Neurotherapeutics, 2015, 12(4), 692-698.
[http://dx.doi.org/10.1007/s13311-015-0374-6] [PMID: 26271952]
[83]
Baswan, S.M.; Klosner, A.E.; Glynn, K.; Rajgopal, A.; Malik, K.; Yim, S.; Stern, N. Therapeutic potential of cannabidiol (CBD) for skin health and disorders. Clin. Cosmet. Investig. Dermatol., 2020, 13, 927-942.
[http://dx.doi.org/10.2147/CCID.S286411] [PMID: 33335413]
[84]
Leinow, L.; Birnbaum, J. CBD: A Patient’s Guide to Medicinal Cannabis--Healing without the High; North Atlantic Books, 2017.
[85]
Bergamaschi, M.M.; Queiroz, R.H.; Zuardi, A.W.; Crippa, J.A. Safety and side effects of cannabidiol, a Cannabis sativa constituent. Curr. Drug Saf., 2011, 6(4), 237-249.
[http://dx.doi.org/10.2174/157488611798280924] [PMID: 22129319]
[86]
Hollister, LE Interactions of Marihuana and THC with Other Drugs: What We Don’t, But Should, Know. Marihuana and medicine., 1999, 1999, 273-277.

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy